Elder Pharmaceuticals

• 

  Anuj Saxena Graft Case: Actor Surrenders In Delhi High Court

  Anuj Saxena surrendered before Delhi High Court in connection with a fraud case

• Cash Flow Situation Tough, but Will Clear All Dues: Elder Pharma

  Troubled drug maker Elder Pharmaceuticals Ltd on Monday said it has been going through tough cash flow situations but asserted it is on the recovery path and has substantial asset base to cover all liabilities.

• Facing Tough Cash Flow, Committed to Repaying Investors: Elder Pharma

  Facing a severe financial crunch, Elder Pharma is in the process of restructuring as a whole and is in advanced stage of discussions with prospective lenders.

• 

  Popular TV Actor Anuj Saxena Faces Rs 1.35 Crore Cheating Charge

  The fraud came to light after Dr Anil Agarwal, proprietor of MAK Ampoules Pvt Ltd and Ankola Paper Mills Pvt Ltd - companies based in Marine Lines which supplied material to Elder Pharmaceuticals - registered an FIR at the Azad Maidan police station on October 2

• 

  Elder Pharma Surges 16% on Asset Sale Plans

  Last year, Elder Pharma had sold its branded domestic formulations business in India and Nepal to Torrent Pharmaceuticals for Rs 2,004 crore.

• 

  Elder Pharma to Consider Sale of Overseas Units

  Elder Pharmaceuticals on Wednesday said its board will meet next week to consider sale of company's overseas subsidiaries.

• 

  Elder Pharma Says Committed to Repay all Creditors

  The statement comes after media reports earlier this week some of the FD deposit-holders had alleged money laundering by the company.

• 

  BSE to Shift 21 Scrips to Restricted Trade Segment

  Bombay Stock Exchange (BSE) will move stocks of as many as 21 companies including Elder Pharmaceuticals and Clutch Auto to restricted trading segment from next week as part of surveillance measures.

• Elder Pharma Enters Mouthwash Category in Oral Care Segment

  Elder Pharmaceuticals on Wednesday said it has entered into fast-growing Rs 600-crore Indian mouthwash category in the oral care segment where the company is eyeing 5-7 per cent share in the next few years.

• Elder Pharma Completes Domestic Formulations Business Sales Transaction

  On December 13 last year, Torrent Pharmaceuticals had agreed to acquire the branded formulation business of Elder Pharmaceuticals in India and Nepal for Rs 2,000 crore to boost its presence in segments such as women's healthcare and pain management.

• No Plans to Invest in UAE Unit: Elder Pharma

  Drugmaker Elder Pharmaceuticals on Tuesday said it has no plans to invest in its wholly-owned subsidiary in the United Arab Emirates.

• Elder Pharma to enter new therapeutics areas to drive growth

  After the Torrent Pharmaceutical deal, pharma firm Elder Pharmaceutical would focus on brand building and enter new therapeutics areas to drive growth.

• Torrent Pharma seeks shareholders' nod for hike in borrowing limit

  Torrent Pharmaceuticals, which has agreed to acquire the branded formulation business of Elder Pharmaceuticals in India and Nepal for Rs 2,000 crore, is seeking shareholders' approval to increase its borrowing limits to Rs 5,000 crore.

• Torrent to acquire formulation business of Elder for Rs 2,000 crore

  Elder's India business comprises a portfolio of 30 brands including some market leading ones in women healthcare, pain management, wound care and neutraceuticals.

• Torrent Pharma to buy Elder's domestic formulation business for Rs 2004 crore

  Torrent Pharma has entered into an agreement with Elder Pharma to acquire its branded domestic formulation business for Rs 2004 crore.